Article info
Multiple sclerosis
Original research
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis
- Correspondence to Dr Nick Cunniffe, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK; ngc26{at}cam.ac.uk
Citation
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis
Publication history
- Received June 16, 2020
- Revised September 8, 2020
- Accepted October 13, 2020
- First published November 12, 2020.
Online issue publication
February 12, 2021
Article Versions
- Previous version (12 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.